Adipose Tissue Immunomodulation: A Novel Therapeutic Approach in Cardiovascular and Metabolic Diseases

Adipose tissue is a critical regulator of systemic metabolism and bodily homeostasis as it secretes a myriad of adipokines, including inflammatory and anti-inflammatory cytokines. As the main storage pool of lipids, subcutaneous and visceral adipose tissues undergo marked hypertrophy and hyperplasia...

Full description

Bibliographic Details
Main Authors: Ibrahim AlZaim, Safaa H. Hammoud, Houssam Al-Koussa, Alaa Ghazi, Ali H. Eid, Ahmed F. El-Yazbi
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-11-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2020.602088/full
_version_ 1818269080848695296
author Ibrahim AlZaim
Ibrahim AlZaim
Safaa H. Hammoud
Houssam Al-Koussa
Alaa Ghazi
Ali H. Eid
Ali H. Eid
Ali H. Eid
Ahmed F. El-Yazbi
Ahmed F. El-Yazbi
author_facet Ibrahim AlZaim
Ibrahim AlZaim
Safaa H. Hammoud
Houssam Al-Koussa
Alaa Ghazi
Ali H. Eid
Ali H. Eid
Ali H. Eid
Ahmed F. El-Yazbi
Ahmed F. El-Yazbi
author_sort Ibrahim AlZaim
collection DOAJ
description Adipose tissue is a critical regulator of systemic metabolism and bodily homeostasis as it secretes a myriad of adipokines, including inflammatory and anti-inflammatory cytokines. As the main storage pool of lipids, subcutaneous and visceral adipose tissues undergo marked hypertrophy and hyperplasia in response to nutritional excess leading to hypoxia, adipokine dysregulation, and subsequent low-grade inflammation that is characterized by increased infiltration and activation of innate and adaptive immune cells. The specific localization, physiology, susceptibility to inflammation and the heterogeneity of the inflammatory cell population of each adipose depot are unique and thus dictate the possible complications of adipose tissue chronic inflammation. Several lines of evidence link visceral and particularly perivascular, pericardial, and perirenal adipose tissue inflammation to the development of metabolic syndrome, insulin resistance, type 2 diabetes and cardiovascular diseases. In addition to the implication of the immune system in the regulation of adipose tissue function, adipose tissue immune components are pivotal in detrimental or otherwise favorable adipose tissue remodeling and thermogenesis. Adipose tissue resident and infiltrating immune cells undergo metabolic and morphological adaptation based on the systemic energy status and thus a better comprehension of the metabolic regulation of immune cells in adipose tissues is pivotal to address complications of chronic adipose tissue inflammation. In this review, we discuss the role of adipose innate and adaptive immune cells across various physiological and pathophysiological states that pertain to the development or progression of cardiovascular diseases associated with metabolic disorders. Understanding such mechanisms allows for the exploitation of the adipose tissue-immune system crosstalk, exploring how the adipose immune system might be targeted as a strategy to treat cardiovascular derangements associated with metabolic dysfunctions.
first_indexed 2024-12-12T20:48:42Z
format Article
id doaj.art-3424fe24b6f94c0aadb85509c63abc5e
institution Directory Open Access Journal
issn 2297-055X
language English
last_indexed 2024-12-12T20:48:42Z
publishDate 2020-11-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Cardiovascular Medicine
spelling doaj.art-3424fe24b6f94c0aadb85509c63abc5e2022-12-22T00:12:29ZengFrontiers Media S.A.Frontiers in Cardiovascular Medicine2297-055X2020-11-01710.3389/fcvm.2020.602088602088Adipose Tissue Immunomodulation: A Novel Therapeutic Approach in Cardiovascular and Metabolic DiseasesIbrahim AlZaim0Ibrahim AlZaim1Safaa H. Hammoud2Houssam Al-Koussa3Alaa Ghazi4Ali H. Eid5Ali H. Eid6Ali H. Eid7Ahmed F. El-Yazbi8Ahmed F. El-Yazbi9Department of Pharmacology and Toxicology, American University of Beirut, Beirut, LebanonDepartment of Biochemistry and Molecular Genetics, American University of Beirut, Beirut, LebanonDepartment of Pharmacology and Therapeutics, Beirut Arab University, Beirut, LebanonDepartment of Pharmacology and Toxicology, American University of Beirut, Beirut, LebanonDepartment of Pharmacology and Toxicology, American University of Beirut, Beirut, LebanonDepartment of Pharmacology and Therapeutics, Faculty of Medicine, American University of Beirut, Beirut, LebanonDepartment of Basic Medical Sciences, College of Medicine, Qatar University, Doha, QatarBiomedical and Pharmaceutical Research Unit, QU Health, Qatar University, Doha, QatarDepartment of Pharmacology and Toxicology, American University of Beirut, Beirut, LebanonDepartment of Pharmacology and Toxicology, Faculty of Pharmacy, Alexandria University, Alexandria, EgyptAdipose tissue is a critical regulator of systemic metabolism and bodily homeostasis as it secretes a myriad of adipokines, including inflammatory and anti-inflammatory cytokines. As the main storage pool of lipids, subcutaneous and visceral adipose tissues undergo marked hypertrophy and hyperplasia in response to nutritional excess leading to hypoxia, adipokine dysregulation, and subsequent low-grade inflammation that is characterized by increased infiltration and activation of innate and adaptive immune cells. The specific localization, physiology, susceptibility to inflammation and the heterogeneity of the inflammatory cell population of each adipose depot are unique and thus dictate the possible complications of adipose tissue chronic inflammation. Several lines of evidence link visceral and particularly perivascular, pericardial, and perirenal adipose tissue inflammation to the development of metabolic syndrome, insulin resistance, type 2 diabetes and cardiovascular diseases. In addition to the implication of the immune system in the regulation of adipose tissue function, adipose tissue immune components are pivotal in detrimental or otherwise favorable adipose tissue remodeling and thermogenesis. Adipose tissue resident and infiltrating immune cells undergo metabolic and morphological adaptation based on the systemic energy status and thus a better comprehension of the metabolic regulation of immune cells in adipose tissues is pivotal to address complications of chronic adipose tissue inflammation. In this review, we discuss the role of adipose innate and adaptive immune cells across various physiological and pathophysiological states that pertain to the development or progression of cardiovascular diseases associated with metabolic disorders. Understanding such mechanisms allows for the exploitation of the adipose tissue-immune system crosstalk, exploring how the adipose immune system might be targeted as a strategy to treat cardiovascular derangements associated with metabolic dysfunctions.https://www.frontiersin.org/articles/10.3389/fcvm.2020.602088/fulladipose tissueadipose tissue inflammation-definition of metabolic syndrome-insulin resistance-myokines-systemic inflammationimmunometabolismadipose tissue immunologyadipose tissue browning
spellingShingle Ibrahim AlZaim
Ibrahim AlZaim
Safaa H. Hammoud
Houssam Al-Koussa
Alaa Ghazi
Ali H. Eid
Ali H. Eid
Ali H. Eid
Ahmed F. El-Yazbi
Ahmed F. El-Yazbi
Adipose Tissue Immunomodulation: A Novel Therapeutic Approach in Cardiovascular and Metabolic Diseases
Frontiers in Cardiovascular Medicine
adipose tissue
adipose tissue inflammation-definition of metabolic syndrome-insulin resistance-myokines-systemic inflammation
immunometabolism
adipose tissue immunology
adipose tissue browning
title Adipose Tissue Immunomodulation: A Novel Therapeutic Approach in Cardiovascular and Metabolic Diseases
title_full Adipose Tissue Immunomodulation: A Novel Therapeutic Approach in Cardiovascular and Metabolic Diseases
title_fullStr Adipose Tissue Immunomodulation: A Novel Therapeutic Approach in Cardiovascular and Metabolic Diseases
title_full_unstemmed Adipose Tissue Immunomodulation: A Novel Therapeutic Approach in Cardiovascular and Metabolic Diseases
title_short Adipose Tissue Immunomodulation: A Novel Therapeutic Approach in Cardiovascular and Metabolic Diseases
title_sort adipose tissue immunomodulation a novel therapeutic approach in cardiovascular and metabolic diseases
topic adipose tissue
adipose tissue inflammation-definition of metabolic syndrome-insulin resistance-myokines-systemic inflammation
immunometabolism
adipose tissue immunology
adipose tissue browning
url https://www.frontiersin.org/articles/10.3389/fcvm.2020.602088/full
work_keys_str_mv AT ibrahimalzaim adiposetissueimmunomodulationanoveltherapeuticapproachincardiovascularandmetabolicdiseases
AT ibrahimalzaim adiposetissueimmunomodulationanoveltherapeuticapproachincardiovascularandmetabolicdiseases
AT safaahhammoud adiposetissueimmunomodulationanoveltherapeuticapproachincardiovascularandmetabolicdiseases
AT houssamalkoussa adiposetissueimmunomodulationanoveltherapeuticapproachincardiovascularandmetabolicdiseases
AT alaaghazi adiposetissueimmunomodulationanoveltherapeuticapproachincardiovascularandmetabolicdiseases
AT aliheid adiposetissueimmunomodulationanoveltherapeuticapproachincardiovascularandmetabolicdiseases
AT aliheid adiposetissueimmunomodulationanoveltherapeuticapproachincardiovascularandmetabolicdiseases
AT aliheid adiposetissueimmunomodulationanoveltherapeuticapproachincardiovascularandmetabolicdiseases
AT ahmedfelyazbi adiposetissueimmunomodulationanoveltherapeuticapproachincardiovascularandmetabolicdiseases
AT ahmedfelyazbi adiposetissueimmunomodulationanoveltherapeuticapproachincardiovascularandmetabolicdiseases